Immune Reconstitution Inflammatory Syndrome is a condition that can happen after you start taking medicine for a condition like AIDS. Your immune system gets stronger, which helps fight off infections. However, this strong response can sometimes cause inflammation and other symptoms.
Every report comes from a Lived member, sent anonymously.
Have you tried Prednisone for Immune Reconstitution Inflammatory Syndrome?
Immune reconstitution inflammatory syndrome (IRIS) is a surge of harmful inflammation that can happen when a badly weakened immune system starts to recover. It is best known in people with HIV (human immunodeficiency virus) who have just begun antiretroviral therapy (ART), the daily medicines that control the virus. As ART lets the immune system rebuild, it can suddenly react strongly to an infection already in the body. The result is fever, swelling or other symptoms that can make a person feel worse just as their treatment is starting to work. IRIS takes two main forms. In paradoxical IRIS, an infection that was already diagnosed and improving on treatment, such as tuberculosis (TB), flares up again. In unmasking IRIS, an infection nobody knew about first shows itself, often with unusually intense inflammation. The most common forms affect the skin and mouth and are rarely severe, but IRIS in the lungs or brain can be serious. Similar reactions can occur when other kinds of immune suppression are reversed, such as recovery after chemotherapy, lowering transplant medicines, or stopping certain treatments for multiple sclerosis or rheumatoid arthritis, though these situations are much less studied.
IRIS is not a toxic effect of the HIV medicines themselves. It reflects the recovering immune system responding to germs, or leftover pieces of germs, that it could not respond to before. Infections often involved include TB, cryptococcus (a fungus that can cause meningitis, an infection of the lining around the brain), herpes viruses including the one that causes shingles, and the virus linked to Kaposi sarcoma, a cancer that often appears as dark patches on the skin. The strongest risk factor is starting ART with very advanced immune damage. This is measured by the CD4 count, the number of CD4 white blood cells (the immune cells HIV destroys) in a blood sample. People who start ART with a count of 100 or below are among those at highest risk. Having a widespread or heavy infection when ART begins, a high HIV viral load (the amount of virus in the blood), and starting ART soon after beginning treatment for an infection also raise the risk. As a result, IRIS mostly affects people whose HIV was diagnosed late, after serious infections had already developed.
No single test confirms IRIS. Doctors suspect it from the timing: symptoms typically appear anywhere from a few days to six months after starting ART, often after an earlier infection had been getting better. The pattern of inflammation, such as fever, rapidly swelling lymph nodes or new shadows on a chest X-ray, also fits. The main task is ruling out other explanations that need different treatment. These include a new infection, an infection that is resisting its medicines (for example drug-resistant TB), a reaction to one of the drugs, or medicines not being taken regularly enough to work. Depending on the symptoms, this can involve cultures (growing germs from a sample of blood, sputum or other fluid) and other tests for infection, chest X-rays or scans, and, when the brain may be affected, a lumbar puncture (spinal tap) to examine the fluid around the brain and measure its pressure.
Treatment depends on which infection is involved and how severe the inflammation is. The first step is usually to make sure the underlying infection is being treated as effectively as possible, because the inflammation is a reaction to it. Mild IRIS, such as a skin flare or cold sores, is often handled with treatment aimed at the specific germ, such as an antiviral medicine for herpes, plus symptom relief. Nonsteroidal anti-inflammatory drugs (NSAIDs) are sometimes used for milder inflammation, although they have not been tested in trials for treating IRIS. For more serious inflammation, doctors may prescribe a corticosteroid, a medicine that calms the immune response. Prednisone is the only IRIS treatment shown to help in a randomized trial: in people with TB-related IRIS, a four-week course helped them improve faster and need fewer hospital days and procedures. Symptoms can return as the dose is lowered, so some people need a longer course. Steroids carry real trade-offs for someone with a weak immune system, including thrush (a yeast infection of the mouth or throat) and reactivation of other infections, and they can make Kaposi sarcoma worse. In other forms of IRIS, their use is a case-by-case judgment. Severe cases may need hospital care, such as oxygen or repeated spinal taps to relieve pressure around the brain. HIV treatment is almost always continued through IRIS. The flare reflects immune recovery, and stopping ART would leave the person open to more infections and risk the virus becoming resistant to the medicines. Pausing is considered only in rare, life-threatening brain cases or when a drug's side effects are part of the problem. Prevention centers on how ART is started. Before beginning, clinicians look for hidden infections such as TB and cryptococcus so they can be treated first. For most forms of TB, starting ART early reduces deaths among people with low CD4 counts, so it is not put off simply to avoid IRIS. For people starting ART during TB treatment with a CD4 count of 100 or below, a four-week preventive course of prednisone lowered the rate of TB-related IRIS from about 47% to 33% in one trial, without more serious infections. Cryptococcal meningitis is an important exception to starting early: a large trial found more deaths when ART began 1 to 2 weeks after diagnosis than when it waited until about 5 weeks, so ART is usually delayed 4 to 6 weeks after treatment for the meningitis begins.
IRIS usually begins in the first weeks to months after starting ART. Many cases settle as the underlying infection is brought under control, but some, particularly TB-related IRIS, can flare again as treatment is tapered and need a longer course. Feeling sicker soon after starting HIV treatment can be discouraging. IRIS does not mean the HIV treatment is failing, and continuing ART remains the key to rebuilding the immune system and long-term health. How much IRIS affects daily life depends on where the inflammation is. Skin and mouth flares are common and uncomfortable but rarely dangerous. Lung and lymph node flares can mean extra clinic visits, procedures such as draining fluid or a swollen gland, or a hospital stay. IRIS in the brain is the most serious form and carries a real risk of death, which is why the timing of ART after brain infections is planned so carefully. Expect closer follow-up in the first months of ART, with check-ins about new or returning symptoms and blood tests to track the CD4 count and viral load. Taking both the HIV medicines and any infection treatment consistently matters, since missed doses weaken recovery and make it harder to tell IRIS from treatment failure.
If you have recently started HIV treatment, or had another form of immune suppression reversed, mention a mild new rash, cold sores or warts to your care team at your next contact. A rash with fever, blistering or peeling skin, sores in the mouth or eyes, or facial swelling needs assessment the same day, since it can be a serious reaction to a medicine. Call your care team promptly if fever, night sweats, cough or weight loss come back after an infection had been improving, or if lymph nodes swell quickly or become painful. Call within a day or two if a painful, blistering rash appears on one side of the body or face (a sign of shingles), because antiviral treatment works best when started early. Call the same day if the rash is near the eye or there are eye symptoms, since shingles there can threaten vision. Do not stop HIV medicines on your own; your team will decide whether any change is needed. Get emergency care right away for a severe or worsening headache, stiff neck, repeated vomiting, vision changes, confusion, unusual drowsiness, a seizure, new weakness or severe trouble breathing, especially after treatment for cryptococcal meningitis or TB.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Immune Reconstitution Inflammatory Syndrome is like, what's helped you, or ask the community a question.